B. BRAUN SE

Company Snapshot

Founded: 1839
Entity Type: Private
Employees: 64,262
Region: Germany
Revenue: $10,627.5 Millions
Revenue Year: 2025
Segment: Hospital Care
Headquarter: Melsungen, Germany
Key Geographics: Asia-Pacific, North America, Germany, Western Europe, Eastern Europe
Corporate Address: Carl-Braun-Straße 1, Melsungen 34212 , Germany Tel. +49-5661-710 www.bbraun.com

Company Overview

B. Braun SE is a manufacturer of medical technology and pharmaceutical products and a provider of medical services. It provides products and services for medical care, ICUs, anesthesia, emergency care, blood treatment, and surgeries. It operates through three divisions: Hospital care, Aesculap, and Avitum.

B. Braun serves the cardiovascular devices market through its Aesculap segment. The Aesculap division provides solutions to advancing surgical and interventional care for operating rooms and cardiac catheterization labs. The product portfolio supports vascular, joint replacement, and neurosurgery procedures, with a focus on improving patient outcomes and recovery times.

B. Braun has manufacturing sites in the EU, Switzerland, the U.S., Malaysia, Vietnam, and Brazil, and distributes globally through subsidiaries and partners. It has a broad geographic presence, with operations in 64 countries.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

B. BRAUN SE In Reports

Cardiovascular Devices: Global Markets to 2030

BCC Research detailed report on cardiovascular devices market data using 2024 as the base year 2025 as the estimated year, and provides CAGR projections for the 2025–2030 forecast period.

Clinical Nutrition: Global Markets to 2031

Get insights into the clinical nutrition market, including enteral nutrition, parenteral nutrition, infant nutrition, regulatory trends and growth opportunities through 2030.

Chronic Kidney Disease: Global Markets and Technologies

BCC Research detailed report on chronic kidney disease market technologies, providing data from 2024, estimates for 2025, projections of compound annual growth rates through 2030.

Company's Business Segments

  • Hospital Care : Hospital Care uses integrated solutions to improve medical care at the hospital and beyond. Our products help give medical professionals more time to care for patients. Our ready-to-use pharmaceutical products and prepared parenteral nutrition in multi-chamber bags help us make clinical processes safer and more efficient. We offer products for the automated production of customized patient medication and nutrition for seriously ill patients, together with software solutions.
  • Aesculap : Our wide range of practical processes for basic surgical and interventional processes help medical professionals provide the best possible care for the patient. In addition, we empower OR professionals to treat patients according to their individual needs using data-centric digital applications. We also offer digitalization solutions for sterile goods management that are adapted to specialists and processes to achieve clinical excellence while lowering costs. With all these integrated solutions, we are driving advancement in the field of surgery and intervention.
  • Avitum : Avitum develops therapy systems for the needs of chronically ill patients. We use integrated solutions to make treatments simple and efficient while also improving quality of life and making work easier for medical professionals. For patients with other chronic conditions—such as chronic wounds, ostomies or urinary incontinence—we are refining our portfolio with products that are reliable and easy to use, even at home. Our focus on infection prevention and control is based on concepts that utilize advice and training to help reduce the risk of infection in all areas of medical treatment, wherever patient care takes place.

Applications/End User Industries

  • Extracorporeal Blood Purification Therapies
  • Acute Blood Purification
  • Acute Therapies
  • Apheresis Treatment
  • Implantology
  • Sutures
  • Infection Prevention and Control (IPC)
  • Infusion Therapy
  • Fluid and Electrolyte Therapy
  • Vascular Intervention Therapy and Diagnostics
  • Coronary Angioplasty
  • Neurosurgery
  • Gravitational Valves
  • Aneurysm Treatment
  • Nutrition Therapy
  • Oncology
  • Chemotherapy
  • Ostomy
  • Anesthesia
  • Spine Surgery
  • Healthcare
  • Life Sciences
AI Sentiment